Lancet 381 (9869): 805-16, 2013.[PUBMED Abstract] Albain KS, Barlow WE, Ravdin PM, et al.: Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Lancet 374 (9707): 2055-63, 2009.[PUBMED Abstract] Eisen A, Messersmith J, Franek M, et al.: Adjuvant ovarian ablation in the treatment of premenopausal women with early stage invasive breast cancer.
Ontario, Canada: Cancer Care, 2010.
Evidence-based Series # 1-9: Section 1.Available online.Last accessed April 24, 2025.
Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial.